Home » Dx Focus: OraSure Gets FDA OK for DNA Collection Device; Quest Dengue Test Approved in Brazil

Dx Focus: OraSure Gets FDA OK for DNA Collection Device; Quest Dengue Test Approved in Brazil

Dec 08, 2011
Premium

OraSure Technologies said this week that the US Food and Drug Administration has granted it 510(k) clearance for its Oragene Dx collection device.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

Related Articles

Sep 20, 2012

Product Watch: Akonni TruTip and Illumina TruSeq Sample Prep Kits

Premium
Aug 14, 2014

Independent Study Validates Simplexa Dengue Test as Focus Diagnostics Expands Menu

Premium
Jan 17, 2013

Product Watch: Akonni Biosystems and Sage Science

Premium
Jun 16, 2014

Sequenom Signs NIPT Deal with Quest; Gets FDA Clearance for Impact Dx System, Thrombophilia Test

Sep 25, 2014

FocusDx Simplexa Dengue Test Outperforms Three Other Molecular Assays in Clinical Evaluation

Premium
Oct 03, 2014

Verisante Begins FDA Submission Process for Aura Device

Premium

The Scan

This Week in PLOS

In PLOS this week: new gene linked to ocular coloboma, new statistical model for interrogating gene expression networks, and more.

Things Not Found

With a new collection, PLOS highlights negative results it has published.

Is the Sequencer Half Full or Half Empty?

A pair of researchers examines political leanings and views on genomics, finding more of a role for optimism and pessimism in people's views.

Packs a Punch

The genome of the carnivorous bladderwort is smaller than many other plant genomes, but it still holds on to important genes.

What's Popular?

In PCR

  1. Alere Gets CE Mark for Alere q HIV-1/2 Detect Assay

  2. RainDance Files for IPO Targeting $60M

  3. New Data Supports AR-V7 Testing to Guide Prostate Cancer Treatment

    Premium

  4. Roche Obtains CE Mark for Cobas HBV Viral Load Test

  5. Germany's GNA Biosolutions Developing Ultrafast 'Laser PCR' Ebola Test, Pathogen Testing Platform

    Premium

Sponsorships

Privacy Policy.  Copyright © 2015 Genomeweb LLC.  All Rights Reserved.